Literature DB >> 2823470

Establishment and biological characterization of an in vitro human cytomegalovirus latency model.

J Tanaka1, T Ogura, H Sato, M Hatano.   

Abstract

In an attempt to develop an in vitro human cytomegalovirus (HCMV) latency model system, the growth characteristics of HCMV in a human thyroid papillary carcinoma cell line (TPC-1) were examined. When TPC-1 cultures preheated at 40.5 degrees for 48 hr were infected with HCMV and incubated at a supraoptimal temperature (40.5 degrees), the cultures could be maintained for at least 65 days without detection of infectious virus. In contrast, when the infected cultures were incubated at 37 degrees, HCMV persistently infected cultures were established. HCMV was reactivated from the latently infected cultures by decreasing the incubation temperature from 40.5 to 37 degrees, and the cultures subsequently entered into virus persistent infection. Although HCMV-specific polypeptides which comigrate with the immediate early virus polypeptides and nuclear antigens were continuously detectable in the majority (more than 95%) of the cells during the latent period, a detectable level of virus-specified DNA polymerase (one of the early virus proteins) was not induced, suggesting that the blockage of HCMV replication in the latently infected cultures occurs at the early stages of the HCMV replication cycle. Infectious center assay revealed that 0.002 to 0.2% of the cells contain an HCMV genome that can be activated during the latent period. The latently infected cells were susceptible to superinfection with homologous and heterologous strains of HCMV. In persistently infected cultures approximately 38% of the cells were lysed by reaction with HCMV immune serum and complement, whereas complement-mediated immune cytolysis could not be detected in the latently infected cultures. The data presented suggest that a temperature-sensitive cellular function(s) that controls the expression of the HCMV early functions plays an important role in maintenance of the HCMV genome in the latent state and reactivation of HCMV by decreasing the incubation temperature.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823470     DOI: 10.1016/0042-6822(87)90171-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  Homologous chromosomes make contact at the sites of double-strand breaks in genes in somatic G0/G1-phase human cells.

Authors:  Manoj Gandhi; Viktoria N Evdokimova; Karen T Cuenco; Marina N Nikiforova; Lindsey M Kelly; James R Stringer; Christopher J Bakkenist; Yuri E Nikiforov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

Authors:  Kevin T Bauerle; Rebecca E Schweppe; Gregory Lund; Gregory Kotnis; Gagan Deep; Rajesh Agarwal; Nikita Pozdeyev; William M Wood; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

3.  Robust Thyroid Gene Expression and Radioiodine Uptake Induced by Simultaneous Suppression of BRAF V600E and Histone Deacetylase in Thyroid Cancer Cells.

Authors:  Weiwei Cheng; Rengyun Liu; Guangwu Zhu; Hui Wang; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2016-01-11       Impact factor: 5.958

4.  A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.

Authors:  R Piccoli; S Di Gaetano; C De Lorenzo; M Grauso; C Monaco; D Spalletti-Cernia; P Laccetti; J Cinátl; J Matousek; G D'Alessio
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.

Authors:  Rong Zeng; Yi Lyu; Guoqiao Zhang; Tao Shou; Kai Wang; Heng Niu; Xinmin Yan
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

6.  Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

Authors:  Samantha K McCarty; Motoyasu Saji; Xiaoli Zhang; David Jarjoura; Alfredo Fusco; Vasyl V Vasko; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2010-10-29       Impact factor: 5.678

7.  MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition.

Authors:  Christina M Knippler; Motoyasu Saji; Neel Rajan; Kyle Porter; Krista M D La Perle; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2019-08       Impact factor: 5.678

8.  Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.

Authors:  Laura A Marlow; Stephen D Rohl; James L Miller; Jeffery A Knauf; James A Fagin; Mabel Ryder; Dragana Milosevic; Brian C Netzel; Stefan K Grebe; Honey V Reddi; Robert C Smallridge; John A Copland
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

9.  Proteomic analysis of human thyroid cell lines reveals reduced nuclear localization of Mn-SOD in poorly differentiated thyroid cancer cells.

Authors:  D Russo; A Bisca; M Celano; F Talamo; F Arturi; A Scipioni; I Presta; S Bulotta; E Ferretti; S Filetti; A Scaloni; G Damante; G Tell
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

10.  Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.

Authors:  Yihui Ma; Samantha K McCarty; Naval P Kapuriya; Victoria J Brendel; Chaojie Wang; Xiaoli Zhang; David Jarjoura; Motoyasu Saji; Ching-Shih Chen; Matthew D Ringel
Journal:  J Clin Endocrinol Metab       Date:  2013-05-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.